[HTML][HTML] Two distinct immunopathological profiles in autopsy lungs of COVID-19

R Nienhold, Y Ciani, VH Koelzer, A Tzankov… - Nature …, 2020 - nature.com
R Nienhold, Y Ciani, VH Koelzer, A Tzankov, JD Haslbauer, T Menter, N Schwab, M Henkel…
Nature communications, 2020nature.com
Abstract Coronavirus Disease 19 (COVID-19) is a respiratory disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has grown to a worldwide
pandemic with substantial mortality. Immune mediated damage has been proposed as a
pathogenic factor, but immune responses in lungs of COVID-19 patients remain poorly
characterized. Here we show transcriptomic, histologic and cellular profiles of post mortem
COVID-19 (n= 34 tissues from 16 patients) and normal lung tissues (n= 9 tissues from 6 …
Abstract
Coronavirus Disease 19 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has grown to a worldwide pandemic with substantial mortality. Immune mediated damage has been proposed as a pathogenic factor, but immune responses in lungs of COVID-19 patients remain poorly characterized. Here we show transcriptomic, histologic and cellular profiles of post mortem COVID-19 (n = 34 tissues from 16 patients) and normal lung tissues (n = 9 tissues from 6 patients). Two distinct immunopathological reaction patterns of lethal COVID-19 are identified. One pattern shows high local expression of interferon stimulated genes (ISGhigh) and cytokines, high viral loads and limited pulmonary damage, the other pattern shows severely damaged lungs, low ISGs (ISGlow), low viral loads and abundant infiltrating activated CD8+ T cells and macrophages. ISGhigh patients die significantly earlier after hospitalization than ISGlow patients. Our study may point to distinct stages of progression of COVID-19 lung disease and highlights the need for peripheral blood biomarkers that inform about patient lung status and guide treatment.
nature.com